Consistent with previous studies, protein kinase CAMP-activated catalytic subunit beta (PRKACB) had a significant discrepancy of expression in normal and tumor tissues and it was also associated with poor patient-free survival and overall survival38. Here, PRKACB is linked to neoplasm.